Monthly
US$200
Billed every month
Sign in to subscribeCelecoxib Capsules
Matched- Active ingredients (original)
- CELECOXIB
- Dosage form (original)
- CAPSULE
- Route (original)
- ORAL
Read these limits
- US patent expiration does not establish Chinese patent expiration. Dates here come from the US Orange Book; Chinese patent status needs separate checking.
- The Orange Book lists holder-submitted patents and does not cover all related patents.
- “Unmatched” means no English ingredient-name counterpart in the Chinese official-name sources loaded here; it does not mean no Chinese approval or filing. A zero count means a Chinese name is matched but no records were found in the loaded source. Source dates appear below.
- This page contains no sales or market-size data and cannot establish development value.
- Names on unmatched rows are the original FDA Orange Book names, without Chinese translation. The same ingredient may have a different generic name in China.
US-approved products
Application numbers, product numbers and original fields are retained. Marketing status is shown as listed in the source.
Earliest approval1998/12/31
ANDA applications26
RLD applicantUPJOHN US 2 LLC
Currently marketed products: 71 · Counts FDA prescription and OTC marketing categories as listed; discontinued or unknown categories are excluded.
| Application / product number | Brand name (original) | Applicant (original) | Dosage form (original) | Route (original) | Strength (original) | Earliest approval | RLD / RS | Marketing status (original) | Official source |
|---|---|---|---|---|---|---|---|---|---|
| A076898-001 | CELECOXIB | TEVA PHARMACEUTICALS USA INC | CAPSULE | ORAL | CELECOXIB: 50MG | 2014/05/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A076898-002 | CELECOXIB | TEVA PHARMACEUTICALS USA INC | CAPSULE | ORAL | CELECOXIB: 100MG | 2014/05/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A076898-003 | CELECOXIB | TEVA PHARMACEUTICALS USA INC | CAPSULE | ORAL | CELECOXIB: 200MG | 2014/05/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A076898-004 | CELECOXIB | TEVA PHARMACEUTICALS USA INC | CAPSULE | ORAL | CELECOXIB: 400MG | 2014/05/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A078857-001 | CELECOXIB | PHARMAZONE | CAPSULE | ORAL | CELECOXIB: 50MG | 2014/05/30 | N / N | DISCONTINUED | openFDA ↗ |
| A078857-002 | CELECOXIB | PHARMAZONE | CAPSULE | ORAL | CELECOXIB: 100MG | 2015/02/11 | N / N | DISCONTINUED | openFDA ↗ |
| A078857-003 | CELECOXIB | PHARMAZONE | CAPSULE | ORAL | CELECOXIB: 200MG | 2015/02/11 | N / N | DISCONTINUED | openFDA ↗ |
| A078857-004 | CELECOXIB | PHARMAZONE | CAPSULE | ORAL | CELECOXIB: 400MG | 2015/02/11 | N / N | DISCONTINUED | openFDA ↗ |
| A200562-001 | CELECOXIB | WATSON LABORATORIES INC | CAPSULE | ORAL | CELECOXIB: 50MG | 2015/02/11 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A200562-002 | CELECOXIB | WATSON LABORATORIES INC | CAPSULE | ORAL | CELECOXIB: 100MG | 2015/02/11 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A200562-003 | CELECOXIB | WATSON LABORATORIES INC | CAPSULE | ORAL | CELECOXIB: 200MG | 2015/02/11 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A200562-004 | CELECOXIB | WATSON LABORATORIES INC | CAPSULE | ORAL | CELECOXIB: 400MG | 2015/02/11 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A202240-001 | CELECOXIB | LUPIN LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2014/10/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A202240-002 | CELECOXIB | LUPIN LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2015/06/09 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A202240-003 | CELECOXIB | LUPIN LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2015/06/09 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A202240-004 | CELECOXIB | LUPIN LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2015/06/09 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204197-001 | CELECOXIB | APOTEX INC | CAPSULE | ORAL | CELECOXIB: 50MG | 2015/06/02 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204197-002 | CELECOXIB | APOTEX INC | CAPSULE | ORAL | CELECOXIB: 100MG | 2015/06/02 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204197-003 | CELECOXIB | APOTEX INC | CAPSULE | ORAL | CELECOXIB: 200MG | 2015/06/02 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204519-001 | CELECOXIB | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2015/08/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204519-002 | CELECOXIB | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2015/08/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204519-003 | CELECOXIB | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2015/08/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204519-004 | CELECOXIB | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2015/08/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204590-001 | CELECOXIB | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2016/03/16 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204590-002 | CELECOXIB | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2016/03/16 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204590-003 | CELECOXIB | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2016/03/16 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204590-004 | CELECOXIB | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2016/03/16 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204776-001 | CELECOXIB | MICRO LABS LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2018/04/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204776-002 | CELECOXIB | MICRO LABS LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2018/04/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204776-003 | CELECOXIB | MICRO LABS LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2018/04/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204776-004 | CELECOXIB | MICRO LABS LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2018/04/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205129-001 | CELECOXIB | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | CELECOXIB: 50MG | 2020/12/03 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205129-002 | CELECOXIB | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | CELECOXIB: 100MG | 2020/12/03 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205129-003 | CELECOXIB | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | CELECOXIB: 200MG | 2020/12/03 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205129-004 | CELECOXIB | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | CELECOXIB: 400MG | 2020/12/03 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205938-001 | CELECOXIB | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | CELECOXIB: 50MG | 2025/07/14 | N / N | DISCONTINUED | openFDA ↗ |
| A205938-002 | CELECOXIB | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | CELECOXIB: 100MG | 2025/07/14 | N / N | DISCONTINUED | openFDA ↗ |
| A205938-003 | CELECOXIB | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | CELECOXIB: 200MG | 2025/07/14 | N / N | DISCONTINUED | openFDA ↗ |
| A205938-004 | CELECOXIB | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | CELECOXIB: 400MG | 2025/07/14 | N / N | DISCONTINUED | openFDA ↗ |
| A206827-001 | CELECOXIB | AUROBINDO PHARMA LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2016/02/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206827-002 | CELECOXIB | AUROBINDO PHARMA LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2016/02/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206827-003 | CELECOXIB | AUROBINDO PHARMA LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2016/02/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206827-004 | CELECOXIB | AUROBINDO PHARMA LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2016/02/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207061-001 | CELECOXIB | JUBILANT GENERICS LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2017/04/04 | N / N | DISCONTINUED | openFDA ↗ |
| A207061-002 | CELECOXIB | JUBILANT GENERICS LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2017/04/04 | N / N | DISCONTINUED | openFDA ↗ |
| A207061-003 | CELECOXIB | JUBILANT GENERICS LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2017/04/04 | N / N | DISCONTINUED | openFDA ↗ |
| A207061-004 | CELECOXIB | JUBILANT GENERICS LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2017/04/04 | N / N | DISCONTINUED | openFDA ↗ |
| A207446-001 | CELECOXIB | CIPLA LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2015/09/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207446-002 | CELECOXIB | CIPLA LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2015/09/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207446-003 | CELECOXIB | CIPLA LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2015/09/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207446-004 | CELECOXIB | CIPLA LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2015/09/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207677-001 | CELECOXIB | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2015/12/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207677-002 | CELECOXIB | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2015/12/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207677-003 | CELECOXIB | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2015/12/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207677-004 | CELECOXIB | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2015/12/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207872-001 | CELECOXIB | TIANJIN TIANYAO PHARMACEUTICALS CO LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2020/02/25 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207872-002 | CELECOXIB | TIANJIN TIANYAO PHARMACEUTICALS CO LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2020/02/25 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207872-003 | CELECOXIB | TIANJIN TIANYAO PHARMACEUTICALS CO LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2020/02/25 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207872-004 | CELECOXIB | TIANJIN TIANYAO PHARMACEUTICALS CO LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2020/02/25 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208701-001 | CELECOXIB | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2019/11/14 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208701-002 | CELECOXIB | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2019/11/14 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208701-003 | CELECOXIB | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2019/11/14 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208701-004 | CELECOXIB | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2019/11/14 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208833-001 | CELECOXIB | AMNEAL PHARMACEUTICALS OF NEW YORK LLC | CAPSULE | ORAL | CELECOXIB: 50MG | 2018/05/31 | N / N | DISCONTINUED | openFDA ↗ |
| A208833-002 | CELECOXIB | AMNEAL PHARMACEUTICALS OF NEW YORK LLC | CAPSULE | ORAL | CELECOXIB: 100MG | 2018/05/31 | N / N | DISCONTINUED | openFDA ↗ |
| A208833-003 | CELECOXIB | AMNEAL PHARMACEUTICALS OF NEW YORK LLC | CAPSULE | ORAL | CELECOXIB: 200MG | 2018/05/31 | N / N | DISCONTINUED | openFDA ↗ |
| A208833-004 | CELECOXIB | AMNEAL PHARMACEUTICALS OF NEW YORK LLC | CAPSULE | ORAL | CELECOXIB: 400MG | 2018/05/31 | N / N | DISCONTINUED | openFDA ↗ |
| A208856-001 | CELECOXIB | QINGDAO BAHEAL PHARMACEUTICAL CO LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2019/08/07 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208856-002 | CELECOXIB | QINGDAO BAHEAL PHARMACEUTICAL CO LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2019/08/07 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208856-003 | CELECOXIB | QINGDAO BAHEAL PHARMACEUTICAL CO LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2019/08/07 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208856-004 | CELECOXIB | QINGDAO BAHEAL PHARMACEUTICAL CO LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2019/08/07 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210071-001 | CELECOXIB | CSPC OUYI PHARMACEUTICAL CO LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2018/01/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210071-002 | CELECOXIB | CSPC OUYI PHARMACEUTICAL CO LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2018/01/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210071-003 | CELECOXIB | CSPC OUYI PHARMACEUTICAL CO LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2018/01/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210628-001 | CELECOXIB | PHARMAZONE | CAPSULE | ORAL | CELECOXIB: 50MG | 2019/11/27 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210628-002 | CELECOXIB | PHARMAZONE | CAPSULE | ORAL | CELECOXIB: 100MG | 2019/11/27 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210628-003 | CELECOXIB | PHARMAZONE | CAPSULE | ORAL | CELECOXIB: 200MG | 2019/11/27 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210628-004 | CELECOXIB | PHARMAZONE | CAPSULE | ORAL | CELECOXIB: 400MG | 2019/11/27 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211412-001 | CELECOXIB | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | CELECOXIB: 50MG | 2020/03/06 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211412-002 | CELECOXIB | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | CELECOXIB: 100MG | 2020/03/06 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211412-003 | CELECOXIB | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | CELECOXIB: 200MG | 2020/03/06 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211412-004 | CELECOXIB | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | CELECOXIB: 400MG | 2020/03/06 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212564-001 | CELECOXIB | YABAO PHARMACEUTICAL CO LTD BEIJING | CAPSULE | ORAL | CELECOXIB: 100MG | 2023/04/10 | N / N | DISCONTINUED | openFDA ↗ |
| A212564-002 | CELECOXIB | YABAO PHARMACEUTICAL CO LTD BEIJING | CAPSULE | ORAL | CELECOXIB: 200MG | 2023/04/10 | N / N | DISCONTINUED | openFDA ↗ |
| A212564-003 | CELECOXIB | YABAO PHARMACEUTICAL CO LTD BEIJING | CAPSULE | ORAL | CELECOXIB: 400MG | 2023/04/10 | N / N | DISCONTINUED | openFDA ↗ |
| A212925-001 | CELECOXIB | PANGEA PHARMACEUTICALS LLC | CAPSULE | ORAL | CELECOXIB: 200MG | 2020/12/09 | N / N | DISCONTINUED | openFDA ↗ |
| A212925-002 | CELECOXIB | PANGEA PHARMACEUTICALS LLC | CAPSULE | ORAL | CELECOXIB: 400MG | 2020/12/09 | N / N | DISCONTINUED | openFDA ↗ |
| A213127-001 | CELECOXIB | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2025/04/29 | N / N | DISCONTINUED | openFDA ↗ |
| A213127-002 | CELECOXIB | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2025/04/29 | N / N | DISCONTINUED | openFDA ↗ |
| A213127-003 | CELECOXIB | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2025/04/29 | N / N | DISCONTINUED | openFDA ↗ |
| A213301-001 | CELECOXIB | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | CELECOXIB: 50MG | 2021/01/12 | N / N | DISCONTINUED | openFDA ↗ |
| A213301-002 | CELECOXIB | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | CELECOXIB: 100MG | 2021/01/12 | N / N | DISCONTINUED | openFDA ↗ |
| A213301-003 | CELECOXIB | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2021/01/12 | N / N | DISCONTINUED | openFDA ↗ |
| A213301-004 | CELECOXIB | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | CELECOXIB: 400MG | 2021/01/12 | N / N | DISCONTINUED | openFDA ↗ |
| A213598-001 | CELECOXIB | NANJING SIMCERE DONGYUAN PHARMACEUTICAL CO LTD | CAPSULE | ORAL | CELECOXIB: 200MG | 2020/05/13 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N020998-001 | CELEBREX | UPJOHN US 2 LLC | CAPSULE | ORAL | CELECOXIB: 100MG | 1998/12/31 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N020998-002 | CELEBREX | UPJOHN US 2 LLC | CAPSULE | ORAL | CELECOXIB: 200MG | 1998/12/31 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N020998-003 | CELEBREX | UPJOHN US 2 LLC | CAPSULE | ORAL | CELECOXIB: 400MG | 2002/08/29 | Y / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N020998-004 | CELEBREX | UPJOHN US 2 LLC | CAPSULE | ORAL | CELECOXIB: 50MG | 2006/12/15 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
Listed US patents
*PED rows, substance/product flags, use codes and delisting-request flags are retained without determining legal effect.
Latest listed patent expiration—
Substance patent expiration (DS flag)—
This column includes only source rows explicitly flagged DS. A PED row without that flag is not assigned one by this site.
| Application / product number | Patent number | Listed expiration | Substance / product flags | Use code | Delisting request | Official source |
|---|---|---|---|---|---|---|
| Not listed | ||||||
Exclusivity source records
FDA exclusivity code list ↗Latest exclusivity expiration: —
| Application / product number | Exclusivity code | Listed expiration | Official source |
|---|---|---|---|
| Not listed | |||
Chinese record details
Chinese product landscape ↗The four-zero filter applies only to matched rows: catalog holders, NHSA approval numbers, applications under review, and companies filing generics this year. Unmatched rows have no Chinese counts. Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Catalog holders 27
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H202560590.2g | 2025/11/25 | Official source ↗ |
| Hui Zhi Pharmaceutical (Da Lian) Co., Ltd. romanized | 国药准字H202546520.2g | 2025/06/24 | Official source ↗ |
| Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H202498270.2g | 2024/12/25 | Official source ↗ |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H202445100.2g | 2024/07/30 | Official source ↗ |
| Beijing Shi Qiao Biopharmaceutical Co., Ltd. romanized | 国药准字H202439170.2g | 2024/06/04 | Official source ↗ |
| Hunan Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | 2024/02/23 | Official source ↗ |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H202432870.2g | 2024/02/23 | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | 2023/12/26 | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | 2023/07/06 | Official source ↗ |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H202334450.1g | 2023/04/11 | Official source ↗ |
| Name not romanized | 国药准字H202334490.2g | 2023/04/11 | Official source ↗ |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H202334460.2g | 2023/04/11 | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | 2022/11/08 | Official source ↗ |
| Beijing Ya Bao Bio Pharma Co., Ltd. romanized | 国药准字H202230180.1g | 2022/01/18 | Official source ↗ |
| Beijing Ya Bao Bio Pharma Co., Ltd. romanized | 国药准字H202230190.2g | 2022/01/18 | Official source ↗ |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H202137790.2g | 2021/10/11 | Official source ↗ |
| Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H202137170.2g | 2021/09/13 | Official source ↗ |
| Yang Zi Jiang Pharma Group Beijing Hai Yan Pharma Co., Ltd. romanized | 国药准字H202135860.2g | 2021/07/20 | Official source ↗ |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H202133830.2g | 2021/05/19 | Official source ↗ |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H202130580.2g | 2021/01/27 | Official source ↗ |
| Beijing Foyou Pharma CO.,LTD | 国药准字H202130330.2g | 2021/01/19 | Official source ↗ |
| Tianjin Jin Yao Pharma Co., Ltd. romanized | 国药准字H202037060.1g | 2020/12/25 | Official source ↗ |
| Tianjin Jin Yao Pharma Co., Ltd. romanized | 国药准字H202037070.2g | 2020/12/25 | Official source ↗ |
| Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H202034900.2g | 2020/09/14 | Official source ↗ |
| Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H202034890.1g | 2020/09/14 | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033560.1g | 2020/07/29 | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033570.2g | 2020/07/29 | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H202033250.2g | 2020/07/21 | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H202033240.1g | 2020/07/21 | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H202032970.2g | 2020/07/08 | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H202032960.1g | 2020/07/08 | Official source ↗ |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H201934140.2g | 2019/12/26 | Official source ↗ |
| Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | 国药准字H201933490.2g | 2019/11/28 | Official source ↗ |
| G.D.Searle LLC | H20140107;H201401060.2g | 2000/08/04 | Official source ↗ |
NHSA approval numbers 36
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Beijing Shi Qiao Biopharmaceutical Co., Ltd. romanized | 国药准字H202439170.2g | — | Official source ↗ |
| Beijing Foyou Pharma CO.,LTD | 国药准字H202130330.2g | — | Official source ↗ |
| Yang Zi Jiang Pharma Group Beijing Hai Yan Pharma Co., Ltd. romanized | 国药准字H202135860.2g | — | Official source ↗ |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H202432870.2g | — | Official source ↗ |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized | 国药准字H202037070.2g | — | Official source ↗ |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H202445100.2g | — | Official source ↗ |
| Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | 国药准字H201933490.2g | — | Official source ↗ |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H201934140.2g | — | Official source ↗ |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H202137790.2g | — | Official source ↗ |
| Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H202498270.2g | — | Official source ↗ |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H202133830.2g | — | Official source ↗ |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H202643210.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Name not romanized | 国药准字H202334490.2g | — | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H202032960.1g | — | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H202033240.1g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H202560590.2g | — | Official source ↗ |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H202034890.1g | — | Official source ↗ |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H202130580.2g | — | Official source ↗ |
| Beijing Ya Bao Bio Pharma Co., Ltd. romanized | 国药准字H202230180.1g | — | Official source ↗ |
| Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H202137170.2g | — | Official source ↗ |
| G.D.Searle LLC | 国药准字J201400720.2g | — | Official source ↗ |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H202554510.2g | — | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033560.1g | — | Official source ↗ |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H202334450.1g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Hui Zhi Pharmaceutical (Da Lian) Co., Ltd. romanized | 国药准字H202546520.2g | — | Official source ↗ |
| Beijing Shi Qiao Biopharmaceutical Co., Ltd. romanized | 国药准字H202439170.2g | — | Official source ↗ |
| Beijing Foyou Pharma CO.,LTD | 国药准字H202130330.2g | — | Official source ↗ |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H202432870.2g | — | Official source ↗ |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized | 国药准字H202037070.2g | — | Official source ↗ |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H202445100.2g | — | Official source ↗ |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H201934140.2g | — | Official source ↗ |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H202137790.2g | — | Official source ↗ |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H202133830.2g | — | Official source ↗ |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H202643210.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Name not romanized | 国药准字H202334490.2g | — | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H202032960.1g | — | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H202033240.1g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H202560590.2g | — | Official source ↗ |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H202034890.1g | — | Official source ↗ |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H202130580.2g | — | Official source ↗ |
| Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H202137170.2g | — | Official source ↗ |
| G.D.Searle LLC | 国药准字J201400720.2g | — | Official source ↗ |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H202554510.2g | — | Official source ↗ |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H202334450.1g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Hui Zhi Pharmaceutical (Da Lian) Co., Ltd. romanized | 国药准字H202546520.2g | — | Official source ↗ |
| Beijing Shi Qiao Biopharmaceutical Co., Ltd. romanized | 国药准字H202439170.2g | — | Official source ↗ |
| Beijing Foyou Pharma CO.,LTD | 国药准字H202130330.2g | — | Official source ↗ |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H202432870.2g | — | Official source ↗ |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H202445100.2g | — | Official source ↗ |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H201934140.2g | — | Official source ↗ |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H202137790.2g | — | Official source ↗ |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H202643210.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Name not romanized | 国药准字H202334490.2g | — | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H202033240.1g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H202130580.2g | — | Official source ↗ |
| Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H202137170.2g | — | Official source ↗ |
| G.D.Searle LLC | 国药准字J201400720.2g | — | Official source ↗ |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H202554510.2g | — | Official source ↗ |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H202334450.1g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Beijing Foyou Pharma CO.,LTD | 国药准字H202130330.2g | — | Official source ↗ |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H202432870.2g | — | Official source ↗ |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H201934140.2g | — | Official source ↗ |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H202137790.2g | — | Official source ↗ |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H202643210.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Name not romanized | 国药准字H202334490.2g | — | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H202033240.1g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H202137170.2g | — | Official source ↗ |
| G.D.Searle LLC | 国药准字J201400720.2g | — | Official source ↗ |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H202334450.1g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H202432870.2g | — | Official source ↗ |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H201934140.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Name not romanized | 国药准字H202334490.2g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H202137170.2g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Name not romanized | 国药准字H202334490.2g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Upjohn US 2 LLC | 国药准字HJ201401060.2g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H202432870.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Name not romanized | 国药准字H202334490.2g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Upjohn US 2 LLC | 国药准字HJ201401060.2g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H202432870.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Upjohn US 2 LLC | 国药准字HJ201401060.2g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H202432870.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Upjohn US 2 LLC | 国药准字HJ201401060.2g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202432760.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H202238140.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H202346970.2g | — | Official source ↗ |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H202339110.2g | — | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H202032970.2g | — | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H202033250.2g | — | Official source ↗ |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H202034900.2g | — | Official source ↗ |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H202130580.2g | — | Official source ↗ |
| Beijing Ya Bao Bio Pharma Co., Ltd. romanized | 国药准字H202230190.2g | — | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033570.2g | — | Official source ↗ |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H202334460.2g | — | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H202032970.2g | — | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H202033250.2g | — | Official source ↗ |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H202034900.2g | — | Official source ↗ |
| Beijing Ya Bao Bio Pharma Co., Ltd. romanized | 国药准字H202230190.2g | — | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033570.2g | — | Official source ↗ |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H202334460.2g | — | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H202032970.2g | — | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H202033250.2g | — | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033570.2g | — | Official source ↗ |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H202334460.2g | — | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H202032970.2g | — | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H202033250.2g | — | Official source ↗ |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H202034900.2g | — | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033570.2g | — | Official source ↗ |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H202334460.2g | — | Official source ↗ |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H202034900.2g | — | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033570.2g | — | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033570.2g | — | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033570.2g | — | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033570.2g | — | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H202033570.2g | — | Official source ↗ |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H202643210.2g | — | Official source ↗ |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H202643210.2g | — | Official source ↗ |
Under review 5
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Di Sha Pharma Group Co., Ltd. romanized | CYHS2600766 | 2026/04/02 | Official source ↗ |
| Shaanxi Xi Yue Pharmaceutical Co., Ltd. romanized | CYHS2601941 | 2026/08/10 | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | CYHB2601446 | 2026/07/28 | Official source ↗ |
| Jilin Ya Tai Yong An Tang Pharma Co., Ltd. romanized | CYHS2502959 | 2025/08/13 | Official source ↗ |
| Jilin Ya Tai Yong An Tang Pharma Co., Ltd. romanized | CYHS2502958 | 2025/08/13 | Official source ↗ |
Generic-filing companies this year 2
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Di Sha Pharma Group Co., Ltd. romanized | CYHS2600766 | 2026/04/02 | Official source ↗ |
| Shaanxi Xi Yue Pharmaceutical Co., Ltd. romanized | CYHS2601941 | 2026/08/10 | Official source ↗ |
API companies with A status 38
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | Y20240001315 | 2026/06/17 | Official source ↗ |
| Jiangxi Tong He Pharma Co., Ltd. romanized | Y20240001113 | 2026/05/28 | Official source ↗ |
| Shandong Lukang Pharmaceutical Co.,Ltd. | Y20230001246 | 2025/04/30 | Official source ↗ |
| Anhui Yue Kang Kai Yue Pharmaceutical Co., Ltd. romanized | Y20230000906 | 2025/07/04 | Official source ↗ |
| Qian Hui Pharma (Anhui) Co., Ltd. romanized | Y20230000649 | 2024/12/30 | Official source ↗ |
| Kunming Yuan Rui Pharmaceutical Co., Ltd. romanized | Y20230000320 | 2024/09/25 | Official source ↗ |
| Shandong Dao He Pharma Co., Ltd. romanized | Y20230000076 | 2024/06/28 | Official source ↗ |
| Hubei Sheng Hong Yuan Pharma Technology Co., Ltd. romanized | Y20210000794 | 2024/02/08 | Official source ↗ |
| Hunan Jiu Dian Hong Yang Pharmaceutical Co., Ltd. romanized | Y20210000947 | 2024/02/02 | Official source ↗ |
| Upjohn US 2 LLC | Y20200001454 | 2026/04/11 | Official source ↗ |
| Nan Tong Chang You Pharma Technology Co., Ltd. romanized | Y20210000043 | 2023/09/27 | Official source ↗ |
| Henan Dong Tai Pharmaceutical Co., Ltd. romanized | Y20200000335 | 2025/08/09 | Official source ↗ |
| Sichuan Kelun Pharmaceutical Co., Ltd. | Y20190021398 | 2026/03/21 | Official source ↗ |
| Yang Zi Jiang Pharma Group Jiangsu Hai Ci Bio Pharma Co., Ltd. romanized | Y20190021195 | 2026/05/22 | Official source ↗ |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | Y20190009882 | — | Official source ↗ |
| Upjohn US 2 LLC | Y20190009148 | 2024/10/29 | Official source ↗ |
| Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | Y20190007241 | 2023/06/07 | Official source ↗ |
| Sichuan Gowell Pharmaceutical Co., Ltd. | Y20180001644 | 2025/05/07 | Official source ↗ |
| Jiangsu Run An Pharmaceutical Co., Ltd. romanized | Y20180001195 | 2024/12/27 | Official source ↗ |
| Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | Y20180000610 | 2023/07/31 | Official source ↗ |
| Rui Yang Pharmaceutical Co., Ltd. romanized | Y20170002232 | 2026/02/14 | Official source ↗ |
| Jiangxi Tong He Pharma Co., Ltd. romanized | Y20180000172 | 2025/07/04 | Official source ↗ |
| Hunan Fang Sheng Pharmaceutical Co., Ltd. romanized | Y20170001323 | 2024/07/02 | Official source ↗ |
| Fujian Sheng Fu Kang Pharma Co., Ltd. romanized | Y20170001322 | 2025/07/28 | Official source ↗ |
| Di Jia Pharma Group Co., Ltd. romanized | Y20170001274 | 2026/09/01 | Official source ↗ |
| Hubei Mei Lin Pharma Co., Ltd. romanized | Y20170001098 | 2025/04/23 | Official source ↗ |
| Ai Mei Ke Jian (Zhongguo) Biopharmaceuticals Co., Ltd. romanized | Y20170001077 | 2024/01/16 | Official source ↗ |
| Apitoria Pharma Private Limited | Y20170001012 | 2025/09/15 | Official source ↗ |
| Shenzhen Shi Hai Bin Pharmaceutical Co., Ltd. romanized | Y20170000973 | 2024/06/06 | Official source ↗ |
| Ji Ning Shen Zhou Pharmaceuticals Co., Ltd. romanized | Y20170000869 | 2026/04/01 | Official source ↗ |
| Shandong Cheng Hui Shuang Da Pharma Co., Ltd. romanized | Y20170000787 | 2026/07/24 | Official source ↗ |
| Nanjing Yi Hua Pharma Co., Ltd. romanized | Y20170000783 | 2024/10/01 | Official source ↗ |
| Jin Yao Pharma Co., Ltd. romanized | Y20170000774 | 2024/11/26 | Official source ↗ |
| Shandong An Xin Pharmaceutical Co., Ltd. romanized | Y20170000772 | 2026/10/29 | Official source ↗ |
| Macleods Pharmaceuticals Limited | Y20170000770 | 2024/01/17 | Official source ↗ |
| Hubei Hua Shi Tong Biopharmaceuticals Technology Co., Ltd. romanized | Y20170000767 | 2024/02/08 | Official source ↗ |
| Tianjin Shi Zhong Yang Pharma Co., Ltd. romanized | Y20170000723 | 2025/06/05 | Official source ↗ |
| Alembic Pharmaceuticals Limited | Y20170000568 | 2025/02/07 | Official source ↗ |
| Hetero Drugs Limited, Unit-IX | Y20170000465 | 2024/11/26 | Official source ↗ |
| Zhejiang Hai Zheng Pharma Co., Ltd. romanized | Y20170000353 | 2024/09/12 | Official source ↗ |
Trial registrations 2025/2026 —
Not loaded
Sources and dates
- FDA Orange Book
- 2026/11/06
- CDE acceptance and review
- 2026/11/14 06:44
- Chemical Drug Catalog
- 2026/11/14 06:40
- API registration records
- 2026/11/14 06:43
- NHSA drug code database
- 2026/10/23
- Trial registry
- 2026/11/14 08:10 · Incomplete coverage
Chinese counts use complete ingredient, dosage-form and route matches. Unmatched and partial rows show name-source matching only and make no finding about Chinese approvals or filings. Trials cover registration-number years 2025/2026 only.
Comparison generated: 2026/11/14 18:39 · openFDA Orange Book ↗
Name and dosage-form matching sources
- NMPA reference-product directory, Shaanxi MPA republication ↗ · 36-37 · 2021/01/25
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy